| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1998-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604217cbc3cb0a05ffcc1e21f092fbf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_593481c451e57ada2557f8bb6cb2bc63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf0a66d29fd7b290951c5764501bf97b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b27e7d47ff628f4968fded781b69919
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b16847a880dbba4dc7a3a25fee492a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7721b0a137d28f5a304e7716c1bc135 |
| publicationDate |
2003-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0980381-B1 |
| titleOfInvention |
Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| priorityDate |
1997-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |